about
Goblet Cells Contribute to Ocular Surface Immune Tolerance-Implications for Dry Eye Disease.Lacrimal gland-derived IL-22 regulates IL-17-mediated ocular mucosal inflammation.CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease.Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial.Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled studyMesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye.Changes of Ocular Surface and the Inflammatory Response in a Rabbit Model of Short-Term Exposure Keratopathy.Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye DiseaseIL-13 Stimulates Proliferation and Expression of Mucin and Immunomodulatory Genes in Cultured Conjunctival Goblet CellsDual-Polymer Drops, Contact Lens Comfort, and Lid Wiper EpitheliopathyThe IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eyeTranslational Immunoimaging and Neuroimaging Demonstrate Corneal Neuroimmune Crosstalk.Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model.Vitamin D Supplementation for Patients with Dry Eye Syndrome Refractory to Conventional Treatment.The role and treatment of inflammation in dry eye disease.Goblet cells of the conjunctiva: A review of recent findingsLangerhans cells prevent subbasal nerve damage and upregulate neurotrophic factors in dry eye disease.Ageing and ocular surface immunity.Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature.Dry Eye Management: Targeting the Ocular Surface Microenvironment.Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis.TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model.Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome.Correlation of interleukin-33 with Th cytokines and clinical severity of dry eye disease.Correlation of vitamin D levels with tear film stability and secretion in patients with dry eye syndrome.Goblet cell loss abrogates ocular surface immune tolerance.Randomized Controlled Crossover Trial Comparing the Impact of Sham or Intranasal Tear Neurostimulation on Conjunctival Goblet Cell Degranulation.Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose.The association between demodex infestation and ocular surface manifestations in meibomian gland dysfunction.Extended low oxygen transmissibility contact lens use induces alterations in the concentration of proinflammatory cytokines, enzymes and electrolytes in tear fluid.Context-Dependent Regulation of Conjunctival Goblet Cell Function by Allergic Mediators
P2860
Q33755012-2A1B04CC-947C-4274-85F4-754F63DFC5BCQ33870377-AF9D597F-4CD0-4155-A2D5-F8E56B17D63CQ34211406-670B8423-FEDB-4E41-BDAB-E4D859BE8750Q35507058-509D39B9-418B-431E-92D9-A4A110706897Q35532014-2E462BA8-125F-4172-8C3F-4D6891CC44FEQ35591394-98EAB99E-FCF7-41AB-9B8C-470BF1746923Q35762942-1AD3BA32-D05A-4FD8-BCD8-6776CC97CA03Q35773063-6A36889A-FE5B-4946-B361-D63C868B7B2CQ35831266-567D1AA0-D1C3-4F5B-9AE4-EF6631E8992FQ36038395-84BC7EC6-ACFD-4BD4-9DB8-9A5E1042AE0FQ36039088-D1E3C023-B456-4CC6-BB3B-61BB37971A49Q36133749-065C6558-EACE-4926-AF6E-82CF54759379Q36872927-10E5B40C-997D-4B8B-A3BC-C509A4BC5582Q37307601-BC6BCCCC-449B-4A34-B0D1-41998466692CQ38270449-2C0C1644-4ABC-42CD-B00C-D8ED6E2A4598Q38811416-5857B647-2EE1-4353-83E5-B3C41386E278Q38820726-E171CD31-47C4-43DA-B2DF-949E36E5E033Q38886086-0942FDB6-3EBA-4CDF-B395-9959BC964BFAQ39151688-2762A27D-9A3F-4F9F-8FBD-DED3F93F68D3Q39404635-07B544B4-4B46-493B-9D30-5E808B5150CCQ41489266-9471512F-7270-4D1F-9086-AAE5D4483EC8Q47138569-7D3E589F-DDF5-4874-92A1-5F07F7571AC6Q47203561-F1505B22-0998-49FC-8436-BA20D1B9DC21Q47250165-C20D5830-B2B6-4BD1-B81B-B4F400A5F808Q47625440-82511CDA-D214-4894-A55B-924FF871BC4AQ50130535-941F1776-FB39-4F19-B316-50CA0E3D05EEQ52889830-6C1E69BA-F251-4244-82D2-CAE5208935DBQ53818675-542B8245-9D2E-4993-9DB7-FF47461628A4Q54940582-1AEF6414-2008-4CFF-A17E-3FF6BC329530Q55363195-C043F21F-5A43-45F2-AEA8-9655492BC792Q58778591-6AE0D4E9-5673-43AE-9472-45408E52986E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T helper cytokines in dry eye disease
@en
T helper cytokines in dry eye disease.
@nl
type
label
T helper cytokines in dry eye disease
@en
T helper cytokines in dry eye disease.
@nl
prefLabel
T helper cytokines in dry eye disease
@en
T helper cytokines in dry eye disease.
@nl
P2860
P1476
T helper cytokines in dry eye disease
@en
P2093
Rosa M Corrales
Stephen C Pflugfelder
P2860
P304
P356
10.1016/J.EXER.2013.08.013
P577
2013-09-04T00:00:00Z